Clinical trial
Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
NCT00466518 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00466518 |
|---|---|
| Title | Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant |
| Official title | Sitagliptin Treatment in Patients With Type 2 Diabetes Mellitus After Kidney Transplant |
| Lead sponsor | University of Oklahoma, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Kidney Transplant, Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Administration of sitagliptin |
| Enrollment | 16 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Apr 27, 2007 |
| Last update posted | Jun 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: